US Broker Ratings

BioNTech SE (BNTX): Investor Outlook Reveals 26.79% Upside Potential Amid Robust Pipeline

BioNTech SE (NASDAQ: BNTX), a biotechnology powerhouse based in Mainz, Germany, has made impressive strides in the healthcare sector with its innovative approach to developing immunotherapies targeting cancer and infectious..

The Cigna Group (CI) Stock Analysis: Unlocking an 18.66% Potential Upside with Strong Buy Ratings

The Cigna Group (NYSE: CI), a titan in the healthcare plans industry, is drawing significant attention from investors seeking robust returns in a volatile market. With a market capitalization of..

DexCom, Inc. (DXCM): Investor Outlook Highlights 16.94% Upside Potential and Strong Buy Ratings

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, primarily focuses on continuous glucose monitoring (CGM) systems that are vital for diabetes management. Headquartered in..

Axsome Therapeutics (AXSM): A Biotech Powerhouse with Promising Upside Potential and Strong Buy Consensus

Axsome Therapeutics, Inc. (AXSM), a prominent player in the biotechnology sector, has been making significant strides in the field of central nervous system (CNS) disorders. With a market capitalization of..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a -15.68% Potential Downside Amid Revenue Challenges

As a key player in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) has been at the forefront of mRNA technology, revolutionizing how the world approaches vaccines and therapeutics. However, recent..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unpacking a Potential 37.5% Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is drawing significant attention from investors with its robust potential upside of 37.52%, as indicated by its average target price of $176.89 against a current..

Eli Lilly and Company (LLY) Stock Analysis: Exploring a 19.98% Potential Upside in the Healthcare Giant

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio in pharmaceuticals. With a market capitalization nearing the trillion-dollar..

Alkermes plc (ALKS) Stock Analysis: A Strong Buy with 37% Potential Upside

Individual investors eyeing opportunities in the biopharmaceutical sector may find Alkermes plc (NASDAQ: ALKS) a compelling consideration. As a leading player in the healthcare industry, Alkermes focuses on developing innovative..

Bio-Techne Corp (TECH) Stock Analysis: Uncovering the 30.82% Potential Upside for Investors

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the healthcare sector, presents an intriguing investment opportunity with a significant potential upside of 30.82%. This Minneapolis-based biotechnology company specializes in developing,..

Option Care Health, Inc. (OPCH) Stock Analysis: Analyst Ratings Highlight Growth Potential with a 11.57% Upside

For investors with a keen eye on the healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents an intriguing opportunity, especially in the niche of home and alternate site infusion..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the genomics sector, stands at an intriguing juncture for investors. With a market capitalization of $17.99 billion, the company is a key..

Ascendis Pharma A/S (ASND) Investor Outlook: Biotech Growth with 25.95% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a prominent player in the biotechnology sector, is capturing attention with its significant growth potential and a market cap of $13.81 billion. Based in Hellerup,..

AptarGroup, Inc. (ATR) Stock Analysis: Discovering the 11.29% Upside Potential

AptarGroup, Inc. (NYSE: ATR) is a noteworthy player in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. With a market capitalization of $9.52 billion, the company has..

UnitedHealth Group (UNH) Stock Analysis: An Insight Into Its 25.73% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable entity in the healthcare sector, with a towering market capitalization of $262.69 billion. Operating through its diverse segments — UnitedHealthcare, Optum..

Baxter International Inc. (BAX) Stock Analysis: Navigating Through Challenges with Strategic Resilience

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, continues to capture the attention of investors with its expansive portfolio of medical instruments and supplies. Headquartered in Deerfield,..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Powerhouse with a Strong Growth Trajectory

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a testament to enduring success in the medical distribution industry. With a current market capitalization of $116.94 billion,..

Charles River Laboratories (CRL) Stock Analysis: A 16.86% Upside Amidst Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector, has been on the radar of investors due to its significant contributions to the diagnostics and..

Solventum Corporation (SOLV) Stock Analysis: Exploring a Potential 22% Upside in the Healthcare Sector

Solventum Corporation (SOLV), a prominent player in the healthcare sector, is capturing investor attention with its innovative solutions across medical instruments and supplies. With a market capitalization of $12.65 billion,..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating the Diagnostic Frontier with a 2.3% Upside Potential

Exact Sciences Corporation (NASDAQ: EXAS) is carving a niche for itself in the healthcare sector with its innovative cancer screening and diagnostic products. With a market capitalization of $19.74 billion,..

Amgen Inc. (AMGN): Investor Outlook on a Healthcare Giant with a 2.58% Dividend Yield

Amgen Inc. (NASDAQ: AMGN) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $202.02 billion, Amgen’s presence is undeniably..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds